Bioxyne Limited (BXN) Stock Statistics & Valuation Metrics

Bioxyne Limited has a market cap or net worth of AU$54.12M. The enterprise value is ―.

Bioxyne Limited has 2,164,828,600 shares outstanding. The number of shares has decreased by -2.65% in one year.

Bioxyne Limited’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.

The current PE Ratio of Bioxyne Limited is ―. Bioxyne Limited’s PEG ratio is ―.

In the last 12 months, Bioxyne Limited had revenue of 9.33M and earned -13.33M in profits. Earnings per share was -0.01.

In the last 12 months, operating cash flow was -3.59M and capital expenditures -178.47K, giving a free cash flow of -3.77M billion.

Bioxyne Limited pays an annual dividend of ―, resulting in a dividend yield of ―

Bioxyne Limited upcoming earnings date is Aug 27, 2025, TBA Not Confirmed.

Bioxyne Limited as a current ratio of ―, with Debt / Equity ratio of ―

In the past 12 months, Bioxyne Limited has paid -310.64K in taxes.

Bioxyne Limited EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.

Bioxyne Limited has AU$1.03M in cash and marketable securities with AU$673.72K in debt, giving a net cash position of -AU$354.27K billion.

Gross margin is ―, with operating margin of ―, and net profit margin of ―.

The average price target for Bioxyne Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―